Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the valve academic research consortium (VARC)

Journal of Invasive Cardiology

Volumn 23, Issue 8, 2011, Pages 307-312

  Stähli, Barbara E ^a   Bünzli, Reto ^a   Grünenfelder, Jürg ^b   Bühler, Ines ^a   Felix, Christian ^c   Bettex, Dominique ^c   Biaggi, Patric ^a   Tanner, Felix C ^a   Nguyen Kim, Dan Linh ^a   Plass, André ^b   Ge, Heng ^a   Falk, Volkmar ^b   Lüscher, Thomas F ^a   Corti, Roberto ^a   Maier, Willibald ^a   Altwegg, Lukas A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Department of Internal Medicine   (Switzerland)

^c Department of Anesthesiology ^*  (Switzerland)

Author keywords

Edwards Sapien; Medtronic CoreValve; valve replacement

Indexed keywords

ACUTE KIDNEY FAILURE; AGED; AORTA VALVE PROSTHESIS; AORTA VALVE STENOSIS; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DEVICE SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HIGH RISK POPULATION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PACEMAKER; STROKE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT FAILURE;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; MYOCARDIAL INFARCTION; POSTOPERATIVE HEMORRHAGE; TREATMENT OUTCOME;

EID: 80051984494     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: A population-based study. Lancet 2006;368:1005-1011. (Pubitemid 44353666)
2. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220-1225. (Pubitemid 23106200)
3. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: Why are so many denied surgery? Eur Heart J 2005;26:2714-2720. (Pubitemid 41746694)
4. Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol 2007;50:2018-2019. (Pubitemid 350046335)
5. Leon MB, Kodali S, Williams M, et al. Transcatheter aortic valve replacement in patients with critical aortic stenosis: Rationale, device descriptions, early clinical experiences, and perspectives. Semin Thorac Cardiovasc Surg 2006;18:165-174. (Pubitemid 44835260)
6. Bouma BJ, van Den Brink RB, van Der Meulen JH, et al. To operate or not on elderly patients with aortic stenosis: The decision and its consequences. Heart 1999;82:143-148. (Pubitemid 29362861)
7. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-850.
8. Cribier A, Eltchaninoff H, Bash A. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation 2002;106:3006-3008. (Pubitemid 35440280)
9. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: A consensus report from the Valve Academic Research Consortium. Eur Heart J 2011;32:205-217.
10. Gurvitch R, Toggweiler S, Willson AB, et al. Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines. EuroIntervention 2011;7:41-48.
11. Nuis RJ, Piazza N, Van Mieghem NM, et al. In-hospital complications after transcatheter aortic valve implantation revisited according to the valve academic research consortium definitions. Catheter Cardiovasc Interv 2011 May 11 (Epub ahead of print).
12. Patel JH, Mathew ST, Hennebry TA. Transcatheter aortic valve replacement: A potential option for the nonsurgical patient. Clin Cardiol 2009;32:296-301.
13. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755-763. (Pubitemid 47255993)
14. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: A position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008;29:1463-1470. (Pubitemid 351806497)
15. Webb JG, Altwegg L, Boone RH, et al. Transcatheter aortic valve implantation: Impact on clinical and valve-related outcomes. Circulation 2009;119:3009-3016.
16. Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: Early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 2011;32:191-197.
17. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: First results from a multi-center real-world registry. Eur Heart J 2011;32:198-204.
18. Pasic M, Unbehaun A, Dreysse S, et al. Transapical aortic valve implantation in 175 consecutive patients: Excellent outcome in very high-risk patients. J Am Coll Cardiol 2010;56:813-820.
19. Dworakowski R, MacCarthy PA, Monaghan M, et al. Transcatheter aortic valve implantation for severe aortic stenosis-A new paradigm for multidisciplinary intervention: A prospective cohort study. Am Heart J 2010;160:237-243.
20. Al-Attar N, Himbert D, Descoutures F, et al. Transcatheter aortic valve implantation: Selection strategy is crucial for outcome. Ann Thorac Surg 2009;87:1757-1762; discussion pp. 62-63.
21. Ducrocq G, Francis F, Serfaty JM, et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: Incidence and impact on outcome. EuroIntervention 2010;5:666-672.
22. Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation: Predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 2010;31:865-874.
23. Aregger F, Wenaweser P, Hellige GJ, et al. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant 2009;24:2175-2179.
24. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-1607.
25. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) Corevalve Revalving System: Results from the multicenter, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-249.
26. Dewey TM, Brown DL, Das TS, et al. High-risk patients referred for transcatheter aortic valve implantation: Management and outcomes. Ann Thorac Surg 2008;86:1450-1456; discussion pp. 6-7.
27. Ussia GP, Mule M, Barbanti M, et al. Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J 2009;30:1790-1796.
28. Zahn R, Schiele R, Kilkowski C, et al. [Transcatheter aortic valve implantation (TAVI): A new therapeutic option for patients with severe symptomatic aortic stenosis who are not suitable or at high risk for surgical valve replacement]. Dtsch Med Wochenschr 2010;135:1589-1595.
29. Conradi L, Seiffert M, Franzen O, et al. First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention. Clin Res Cardiol 2011;100:311-316.